drugset / Trial / NCT03849027

MethOxyflUraNe at moderaTe High AltItudes for PAIN Management

NCT03849027

Phase 4 Unknown 24 enrolled University of Cape Town
RandomizedCrossoverTriple-blindTreatment

Summary

A randomised, double-blind, cross-over study to assess the analgesic effect of methoxyflurane at moderate high altitudes in a wilderness field setting. Phase IV, randomised, double-blind, cross-over clinical trial to evaluate the analgesic effect of methoxyflurane at moderate high altitudes in a wilderness field setting, in 24 healthy volunteers

Timeline

Start
2019-05
Primary completion
2019-09
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxyflurane Small molecule 3 ml Inhaled

Indications

No indication recorded.